Treatment related severe and fatal adverse events with cetuximab in colorectal cancer patients: a meta-analysis

In this meta-analysis of RCTs, cetuximab was associated with an increased risk of severe adverse events. There is no evidence of an increased risk of fatal adverse events with cetuximab.